H igh volume lower-limb joint arthroplasty centers have generally outperformed lowvolume centers in terms of complications [1] , mortality rates [12] , and Centers for Medicare & Medicaid Services hospital star ratings [1] .
Additional evidence supports the finding that patients undergoing TKA with high-volume surgeons at highvolume hospitals achieve better Hospital Consumer Assessment of Healthcare Providers Systems metrics, better patient-reported outcomes, shorter operative time and length of stay, and lower deep infection, revision, acute myocardial infarction, pulmonary embolism, pneumonia, mortality compared to low-volume centers [1, 6, 12] . Other research seems to confirm that highvolume centers may perform better than low volume centers in hip replacement as well [9] .
But this is not a one-sided argument. Some data have shown that larger, urban, academic facilities had modestly higher risk-standardized readmission rates than smaller, suburban, community hospitals, although there was a wide range of performance with a strong regional effect suggesting that local practice patterns were an important influence [5] . In addition, 10-year revision rates after TKA between high-and low-volume hospitals showed little differences [2] . Furthermore, higher readmission rates at forprofit hospitals may highlight the role of financial incentives favoring utilization [5] .
In the current study, the authors compared the risk of revision surgery within 2 years of the index TKA between low-volume and high-volume hospitals in Germany. They found that the revision rate was higher in lowvolume hospitals (those performing fewer than 145 TKAs per year) than in high-volume hospitals.
Where Do We Need To Go?
All told, gaps in our knowledge remain on this topic. Further research should assess differences in healthcare access, operational structure, hospital setup, and overall practice.
Lower-limb arthroplasties, complex primary arthroplasties, and revisions remain topics of utmost concern for healthcare systems, hospitals, and practitioners as the number of joint replacements are increasing, and the patients undergoing these operations now are younger and more active [7] . A supply crisis for joint replacements jeopardizes current access for our patients, which may drive further the development of high volume centers [4] . However, a few questions remain in confirming the superiority of high-volume centers versus low-volume centers: (1) There are differences between studies offering anywhere between 50 [6] and 645 [12] How Do We Get There?
To answer these questions, thorough analyses must be conducted to identify or validate the essential factors that improve patient's reported pain, function, mobility and expectations and hospital patient's turnover. At a time where technology is ubiquitous in the work environment, hospital records, surgical practice, and patient follow up are all monitored with sophisticated tools that are transforming the data available on joint replacement practice. Reports resulting from these largescale data collection, such as national registries, are beginning to provide evidence on some of these questions, but more still needs to be done [3] . Along with national registries, health service researchers, pharmaceutical companies, and public health organizations are champions for big data analysis, which is on the verge of delivering a cost-effective prospect for improved decision-making in healthcare. Big data has the potential to transform medical practice by using information generated every day to improve the quality and efficiency of care [8] . In their excellent paper on big data, Drs. Travis B. Murdoch, MD, MSc and Allan S. Detsky, MD, PhD concluded: "Analyzing the unstructured data within electronic health records using computational techniques (eg, natural language processing to extract medical concepts from free-text documents) permits finer data acquisition in an automated fashion" [8] .
It is not a surprise to see more and more articles reviewing "big data" and drawing conclusions that will enable healthcare institutions to define the best model of care for joint arthroplasty, particularly TKA. It is always difficult to compare high-volume arthroplasty centers to industrial classical "Tayloristic" organizations [11] , but there are many common areas in which the former can learn from the latter, such as scientific management standard, monitoring practice to improve performance, education of workers and harmony in the team. Results of these studies will shape the new structure of modern hospitals and healthcare organizations like highvolume arthroplasty centers [10] .
